Pfizer enters weight loss drug market with Novo Nordisk, Eli Lilly
CFOTO | Future Publishing | Getty ImagesAs its Covid gains evaporate, Pfizer wants a chunk of the budding weight loss drug market. Analysts say upcoming data on Pfizer's experimental obesity pill, danuglipron, will be crucial in determining…
Read More...
Read More...